PS-101-Inhibition of toll-like receptor 4 using TAK-242 is a novel therapy for prevention and treatment of acute-on-chronic liver failure

2019 ◽  
Vol 70 (1) ◽  
pp. e64-e65
Author(s):  
Mohammed Sheikh ◽  
Cornelius Engelmann ◽  
Abeba Habtesion ◽  
Shreya Sharma ◽  
Stewart Macdonald ◽  
...  
Keyword(s):  
Liver Failure ◽  
Chronic Liver ◽  
Toll Like Receptor ◽  
Chronic Liver Failure ◽  
Toll Like Receptor 4 ◽  
Novel Therapy ◽  
Prevention And Treatment

Toll-like receptor 4 inhibition acts synergistically with G-CSF to prevent organ injury and induce liver regeneration in acute-on-chronic liver failure

2020 ◽  
Vol 73 ◽  
pp. S28
Author(s):  
Cornelius Engelmann ◽  
Fausto Andreola ◽  
Abeba Habtesion ◽  
Simone Novelli ◽  
Annarein Kerbert ◽  
...  
Keyword(s):  
Liver Failure ◽  
Liver Regeneration ◽  
Chronic Liver ◽  
Organ Injury ◽  
Toll Like Receptor ◽  
Chronic Liver Failure ◽  
Toll Like Receptor 4

scholarly journals Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure

2020 ◽  
Vol 73 (1) ◽  
pp. 102-112 ◽  
Author(s):  
Cornelius Engelmann ◽  
Mohammed Sheikh ◽  
Shreya Sharma ◽  
Takayuki Kondo ◽  
Henry Loeffler-Wirth ◽  
...  
Keyword(s):  
Liver Failure ◽  
Therapeutic Target ◽  
Toll Like Receptor ◽  
Toll Like Receptor 4 ◽  
Prevention And Treatment

Association of Toll-like Receptor 3 Polymorphisms with Chronic Hepatitis B and Hepatitis B-Related Acute-on-Chronic Liver Failure

Inflammation ◽  
2012 ◽  
Vol 36 (2) ◽  
pp. 413-418 ◽  
Author(s):  
Yihui Rong ◽  
Haihan Song ◽  
Shaoli You ◽  
Bing Zhu ◽  
Hong Zang ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Liver Failure ◽  
Chronic Hepatitis B ◽  
Chronic Liver ◽  
Toll Like Receptor ◽  
Chronic Liver Failure

scholarly journals Analysis of Treatment of 3 Patients with Acute-on-Chronic Liver Failure

2018 ◽  
Vol 2018 ◽  
pp. 1-4 ◽  
Author(s):  
Jun Lei ◽  
Yi-lan Zeng ◽  
Lv-ye Xu ◽  
Ying Wang
Keyword(s):  
Stem Cell ◽  
Cell Therapy ◽  
Liver Failure ◽  
Stem Cell Therapy ◽  
Chronic Liver ◽  
Supportive Treatment ◽  
Chronic Liver Failure ◽  
Liver Decompensation ◽  
Prevention And Treatment ◽  
New Treatment

Acute-on-chronic liver failure (ACLF) is an acute liver decompensation that occurs within 4 weeks on the basis of chronic liver disease. At present, the treatments of ACLF include general supportive treatment, etiological treatment, prevention and treatment of complications, artificial liver treatment, and liver transplantation. Many studies suggest that stem cell therapy may become a new treatment for patients with ACLF. Our department has also tried the application of this treatment. Now, there are three cases of stem cell therapy for patients with ACLF by our department which will be briefly reported.

FRI-084-Targeting Toll-Like Receptor 4 signalling with TAK-242: A novel therapy for acute liver failure

2019 ◽  
Vol 70 (1) ◽  
pp. e421
Author(s):  
Cornelius Engelmann ◽  
Mohammed Sheikh ◽  
Simone Novelli ◽  
Thomas Berg ◽  
Annarein Kerbert ◽  
...  
Keyword(s):  
Liver Failure ◽  
Acute Liver Failure ◽  
Toll Like Receptor ◽  
Toll Like Receptor 4 ◽  
Novel Therapy
Sign in / Sign up

Export Citation Format

Share Document